Anti-hnRNP K antibody [F45 P9 C7] (ab23644)

ab23644 has been referenced in 6 publications.

• Kumar M  et al. Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer. J Transl Med 13:285 (2015). PubMed: 26318153
• Chauhan SS  et al. Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer. Oncogenesis 4:e147 (2015). IHC . PubMed: 25893634
• Satkunanathan S  et al. Establishment of a novel cell line for the enhanced production of recombinant adeno-associated virus vectors for gene therapy. Hum Gene Ther 25:929-41 (2014). WB . PubMed: 25072415
• van Domselaar R  et al. All Human Granzymes Target hnRNP K That Is Essential for Tumor Cell Viability. J Biol Chem 287:22854-64 (2012). WB . PubMed: 22582387
• Meyerowitz J  et al. C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress. Mol Neurodegener 6:57 (2011). ICC/IF ; Human . PubMed: 21819629
• Matta A  et al. Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma. Int J Cancer 125:1398-406 (2009). IHC-P ; Human . PubMed: 19548310